Close Menu

The lack of a "revolution" following the Human Genome Project may indicate that researchers are not going about studying the link between genes and disease the right way, says Stephan Hall in this month's Scientific American. Proponents of the project foresaw personalized medicine as a possibility by 2010, but now Hall says "the scientific community finds itself sobered and divided." The dividing question is: do common genetic variants cause disease, or do rare genetic variants?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.